Precision medicine requires technologies capable of capturing both molecular heterogeneity and tissue architecture. Unlike conventional bulk approaches, spatial multi-omics preserves tissue context, enabling the characterization of genes, proteins, metabolites, and cell–cell interactions within their native environment. Combined with AI-driven image analysis and multimodal data integration, spatial multi-omics provides a powerful framework for biomarker discovery, patient stratification, and treatment response prediction.
To demonstrate the potential of AI-enabled spatial multi-omics for precision medicine, we applied an established machine learning framework to identify treatment-associated molecular signatures in cervical cancer using integrated proteomic, transcriptomic, and metabolomic data.
Download our poster, recently presented at AI in Oncology Paris to learn more.